These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15280786)

  • 1. A novel CCR5 mutation selectively affects immunoreactivity and fusogenic property of the HIV co-receptor.
    Zhao XY; Lee SS; Wong KH; Chan KC; He ZM; Ma S; Ng F; Chan CC; Ho T; Ng MH; Zheng BJ
    AIDS; 2004 Aug; 18(12):1729-32. PubMed ID: 15280786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patients.
    Malo A; Rommel F; Bogner J; Gruber R; Schramm W; Goebel FD; Riethmüller G; Wank R
    Immunobiology; 1998 Feb; 198(4):485-8. PubMed ID: 9562872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 co-receptor CCR5 and CCR2 mutations among Greeks.
    Papa A; Papadimitriou E; Adwan G; Clewley JP; Malissiovas N; Ntoutsos I; Alexiou S; Antoniadis A
    FEMS Immunol Med Microbiol; 2000 May; 28(1):87-9. PubMed ID: 10767612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CCR2 and CCR5 variants on HIV disease: abstract and commentary.
    Collman RG
    JAMA; 1997 Dec; 278(23):2113-4. PubMed ID: 9403430
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
    Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D
    Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.
    Arendt V; Amand M; Iserentant G; Lemaire M; Masquelier C; Ndayisaba GF; Verhofstede C; Karita E; Allen S; Chevigné A; Schmit JC; Bercoff DP; Seguin-Devaux C
    J Int AIDS Soc; 2019 Sep; 22(9):e25384. PubMed ID: 31486251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a third CCR5 amplicon from CCR5-delta32-heterozygous HIV-1-infected individuals.
    Aikhionbare FO; Newman C; Womack C; Roth WW; Stringer HG; Bond VC
    AIDS; 1999 Aug; 13(12):1585-6. PubMed ID: 10465086
    [No Abstract]   [Full Text] [Related]  

  • 8. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of new mutant sites of HIV-1 coreceptor CCR5 among Saudi populations.
    Abuelsaad AS; Al-Ghamdi AS; Al-Ghamdi AN; Alakkas EA; Alsulaimani AA; Al-Harthi AA; Abdel-Moneim AS
    J Interferon Cytokine Res; 2013 Dec; 33(12):783-9. PubMed ID: 23742258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV.
    Shimoni M; Herschhorn A; Britan-Rosich Y; Kotler M; Benhar I; Hizi A
    Viral Immunol; 2013 Aug; 26(4):277-90. PubMed ID: 23941674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
    Allers K; Schneider T
    Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino- and Carboxyl-Terminal CCR5 Mutations in Brazilian HIV-1-Infected Women and Homology Model of p.L55Q CCR5 Mutant.
    Costa GC; Nunes MR; Jesus JG; Novaes T; Cardoso JF; Sousa Júnior EC; Santos Ede S; Galvão-Castro B; Zanette DL; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):685-91. PubMed ID: 25825809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries for patients. Genes and HIV progression.
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759637
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M; Nogová P; Hábeková M; Staneková D
    Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals.
    Desgranges C; Carvajal P; Afani A; Guzman MA; Sasco A; Sepulveda C
    Immunol Lett; 2001 Mar; 76(2):115-7. PubMed ID: 11274729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
    McNicholl JM; Smith DK; Qari SH; Hodge T
    Emerg Infect Dis; 1997; 3(3):261-71. PubMed ID: 9284370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
    Samson M; Libert F; Doranz BJ; Rucker J; Liesnard C; Farber CM; Saragosti S; Lapoumeroulie C; Cognaux J; Forceille C; Muyldermans G; Verhofstede C; Burtonboy G; Georges M; Imai T; Rana S; Yi Y; Smyth RJ; Collman RG; Doms RW; Vassart G; Parmentier M
    Nature; 1996 Aug; 382(6593):722-5. PubMed ID: 8751444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
    Chalmet K; Van Wanzeele F; Demecheleer E; Dauwe K; Pelgrom J; Van Der Gucht B; Vogelaers D; Plum J; Stuyver L; Vandekerckhove L; Verhofstede C
    Virology; 2008 Sep; 379(2):213-22. PubMed ID: 18692212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.
    Theodorou I; Meyer L; Magierowska M; Katlama C; Rouzioux C
    Lancet; 1997 Apr; 349(9060):1219-20. PubMed ID: 9130946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.